reddyGeneticFunctionalDrivers2017
| Entity | Total | Tier 1 | Tier 2 | Tier 2 Pass | Tier 2 Fail | Fail rate |
|---|---|---|---|---|---|---|
| DLBCL | 60 | 8 | 52 | 23 | 29 | 56% |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
New to this study, DLBCL Tier 1, 8
New to this study, DLBCL Tier 2, 52
DLBCL Tier 2, Pass QC, 23
DLBCL Tier 2, Fail QC, 29
| Novel gene | DLBCL tier | Average variant quality |
|---|---|---|
| ATM | 1 | ★ ★ ★ ☆ ☆ |
| BIRC6 | 1 | ★ ★ ★ ☆ ☆ |
| HIST1H2BC | 1 | ★ ★ ★ ★ ☆ |
| HNRNPU | 1 | ★ ★ ★ ☆ ☆ |
| SETD1B | 1 | ★ ★ ☆ ☆ ☆ |
| TOX | 1 | ★ ★ ★ ☆ ☆ |
| UBE2A | 1 | ★ ★ ★ ☆ ☆ |
| CASP8 | 1 | ★ ★ ★ ☆ ☆ |
| Novel gene | DLBCL tier | Average variant quality | QC outcome |
|---|---|---|---|
| ARID5B | 2 | ★ ★ ★ ★ ☆ | Pass |
| BTBD3 | 2 | ★ ★ ★ ★ ☆ | Pass |
| SETD5 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| ATR | 2 | ★ ★ ★ ☆ ☆ | Pass |
| BRINP3 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| TGFBR2 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| TIPARP | 2 | ★ ★ ★ ☆ ☆ | Pass |
| CD22 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| NF1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| IKBKB | 2 | ★ ★ ★ ☆ ☆ | Pass |
| JUNB | 2 | ★ ★ ★ ☆ ☆ | Pass |
| KCMF1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| MAGT1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| MECOM | 2 | ★ ★ ★ ☆ ☆ | Pass |
| PTPN6 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| MET | 2 | ★ ★ ★ ☆ ☆ | Pass |
| ZFX | 2 | ★ ★ ★ ☆ ☆ | Pass |
| YY1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| FOXP1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| FUBP1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| GOLGA5 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| MSH6 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| MCL1 | 2 | ★ ★ ★ ☆ ☆ | Pass |
| ANKRD17 | 2 | ★ ★ ★ ☆ ☆ | Fail |
| CDC73 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| CHD1 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| CHD8 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| CHST2 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| DCAF6 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| DDX10 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| DICER1 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| HRAS | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| LIN54 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| MAP4K4 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| MSH2 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| GNAS | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| MYB | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| NCOR1 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| NFKB2 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| PHF6 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| PIK3CD | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| PTPRK | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| ZFAT | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| ARID1B | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| RUNX1 | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| CBLB | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| SYK | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| WAC | 2 | ★ ★ ☆ ☆ ☆ | Fail |
| ZBTB7A | 2 | ★ ☆ ☆ ☆ ☆ | Fail |
| RARA | 2 | ★ ☆ ☆ ☆ ☆ | Fail |
| DNMT3A | 2 | ★ ☆ ☆ ☆ ☆ | Fail |
| MARK1 | 2 | ★ ☆ ☆ ☆ ☆ | Fail |
The primary data supporting each of the mutations reported in this study can be viewed in IGV reports along with mutations unique to the GAMBL re-analysis.[@drevalRevisitingReddyDLBCL2023]
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.